Most Read Articles
21 Apr 2020
A bidirectional association exists between alopecia areata (AA) and major depressive disorder (MDD) among probands and unaffected siblings, reveals a study. This suggests that shared familial mechanisms tend to cause AA and MDD.
16 Feb 2020
A 1.5% ruxolitinib cream does not seem to be effective for patients with alopecia areata, a recent phase II study has found.
17 May 2020
Treatment with serlopitant helps lessen pruritus associated with mild-to-moderate psoriasis, results of a phase II trial have shown. This supports the continued development of serlopitant for this condition.
Roshini Claire Anthony, 18 May 2020

Post hoc analyses of the LIBERTY AD SOLO 1 & 2* and ADOL** trials demonstrated significant reductions in pruritus, anxiety, and depression with dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD).

Hydrochlorothiazide use ups risk for Merkel cell carcinoma, malignant adnexal skin tumours

11 Feb 2019

Use of hydrochlorothiazide appears to increase the risk for Merkel cell carcinoma (MCC) and malignant adnexal skin tumours (MAST), a recent study has found.

High use (≥50,000 mg) of hydrochlorothiazide was associated with risk of MCC (adjusted odds ratio [OR], 2.3; 95 percent CI, 1.1–4.8) and MAST (adjusted OR, 3.6; 1.9–7.0). The adjusted ORs increased to 3.3 (1.3–8.3) and 5.6 (2.4–13.3), respectively, with highest use (≥100,000 mg).

There was no risk increase for these tumours in analyses of drugs with similar indications as hydrochlorothiazide. However, a tendency was observed toward a heightened risk for MCC associated with the use of furosemide (OR, 1.9; 0.9–4.0).

In earlier studies, findings showed that hydrochlorothiazide use was associated with a substantially increased risk of nonmelanoma skin cancer, especially squamous cell carcinoma (SCC), as well as lip cancer. [J Am Acad Dermatol 2018;78:673-681.e9; J Intern Med 2017;282:322-331]

The present study used Danish nationwide health registries to identify all patients with incident MCC or MAST during 2004–2015. Patients were matched individually to cancer-free population controls by risk set sampling. Conditional logistic regression was used to estimate the ORs and CIs associated with cumulative use of hydrochlorothiazide.

The study was limited by the absence of data on sun exposure.

“Hydrochlorothiazide use has been associated with markedly increased risk for SCC,” the authors noted. “No previous studies have investigated the association between hydrochlorothiazide use and the risk for MCC and MAST.”

Editor's Recommendations
Most Read Articles
21 Apr 2020
A bidirectional association exists between alopecia areata (AA) and major depressive disorder (MDD) among probands and unaffected siblings, reveals a study. This suggests that shared familial mechanisms tend to cause AA and MDD.
16 Feb 2020
A 1.5% ruxolitinib cream does not seem to be effective for patients with alopecia areata, a recent phase II study has found.
17 May 2020
Treatment with serlopitant helps lessen pruritus associated with mild-to-moderate psoriasis, results of a phase II trial have shown. This supports the continued development of serlopitant for this condition.
Roshini Claire Anthony, 18 May 2020

Post hoc analyses of the LIBERTY AD SOLO 1 & 2* and ADOL** trials demonstrated significant reductions in pruritus, anxiety, and depression with dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD).